The 3D Urology and Prostate Clinics introduce their groundbreaking 3D Prostate Cancer Targeted Treatment, offering innovative and effective solutions...

Exosome-based therapy targets squamous cell carcinomas that are drug-resistant and offers new hope for patients with drug-resistant cancers

Exosome-based therapy targets squamous cell carcinomas that are drug-resistant and offers new hope for patients with drug-resistant cancers

Illumina's cancer biomarker test, TSO Comprehensive, gets approved by the FDA for use as CDx to match patients with targeted therapies.

The first two blood cancer patients in a US-based trial, who had suffered relapses despite having treatment, have now been in remission for up to 120...

Patients born with genetic blindness experienced significant visual improvements after a single treatment with gene therapy developed at the...

Patients born with genetic blindness experienced significant visual improvements after a single treatment with gene therapy developed at the...

After a single gene therapy treatment, patients with genetic blindness experienced new visual moments.

After a single gene therapy treatment, patients with genetic blindness experienced new visual moments.

Breakthrough in triple-negative breast cancer diagnosis: New test improves early detection, offering better outcomes and personalized treatment...